Vivosim Labs Inc (VIVS)

Jun 29, 2026

VivoSim Labs Delays Annual SEC Filing - TipRanks

Jun 29, 2026

Jun 29, 2026

VivoSim presents toxicity testing data at European conference By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

VivoSim Skids on Data - Baystreet.ca

Jun 29, 2026

Jun 29, 2026

VivoSim Labs(VIVS) Stock Options Chain | Quotes & News - Moomoo

Jun 29, 2026

Jun 29, 2026

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting - The Manila Times

Jun 29, 2026

Jun 29, 2026

VivoSim Presents Data Showing Superiority to Competition in - GlobeNewswire

Jun 29, 2026

Jun 27, 2026

Enterprise value to revenue forward of VivoSim Labs, Inc. – NASDAQ:VIVS - TradingView

Jun 27, 2026

Jun 27, 2026

Price to earnings forward of VivoSim Labs, Inc. – NASDAQ:VIVS - TradingView

Jun 27, 2026

Jun 27, 2026

Price to sales forward of VivoSim Labs, Inc. – NASDAQ:VIVS - TradingView

Jun 27, 2026

Jun 26, 2026

VIVS Q3 2025 Earnings: Narrower-Than-Expected Loss Drives Stock HigherConsensus Beat Rate - dars.gov.et

Jun 26, 2026

Jun 16, 2026

VIVS Q3 2025 Earnings: Narrowed Loss Beats Estimates Amid Steady Pipeline ProgressEarnings Beat Alert - dars.gov.et

Jun 16, 2026

Jun 10, 2026

VIVS Q3 2025 Earnings: EPS Surprise Beats Estimates, Revenue UnreportedEstimate Dispersion - newsline.com

Jun 10, 2026

Jun 07, 2026

VivoSim Labs Faces Pressure: VIVS Stock Falls Over 10% as Key Support ApproachesIchimoku TK Cross - newsline.com

Jun 07, 2026

Jun 02, 2026

VIVS Q3 2025 Earnings: EPS Surprise of 10.83% Beats Estimates Amid Pre-Revenue PhaseEPS Surprise History - newsline.com

Jun 02, 2026

May 30, 2026

VIVS Q3 2025 Earnings: EPS Surprises to the Upside Amid Operational FocusPretax Income Report - The Legal Advocate

May 30, 2026

May 29, 2026

VIVS Q3 2025 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionNet Profit Margin - newsline.com

May 29, 2026

May 27, 2026

VIVS Q3 2025 Earnings: EPS Beat on Cost Management Amidst Ongoing DevelopmentEarnings Analysis - The Legal Advocate

May 27, 2026

May 27, 2026

VivoSim Labs VIVS Dips Slightly as Stock Tests Key Support LevelsThe Legal Advocate - The Legal Advocate

May 27, 2026

May 27, 2026

VivoSim Labs (VIVS) News Flow - Moomoo

May 27, 2026

May 26, 2026

VIVSVivoSim Labs Inc Stock Price and Quote - Finviz

May 26, 2026

May 25, 2026

VivoSim Labs Inc. (VIVS) Edges Up 1.49% as It Tests Resistance at $1.43MESA MA - The Legal Advocate

May 25, 2026

May 23, 2026

VIVS Q3 2025 Earnings: EPS Surprise Beats Estimates Amid Unreported RevenueSocial Signal Watchlist - Newser

May 23, 2026

May 22, 2026

VIVS Stock Chart | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill

May 22, 2026

May 20, 2026

VIVS Q4'25 Earnings: EPS estimate is (2.04) USD - TradingView

May 20, 2026

May 19, 2026

VIVS Stock Price, Quote & Chart | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill

May 19, 2026

May 14, 2026

VIVS Q4'25 Earnings: revenue estimate is 54.00K USD - TradingView

May 14, 2026

May 09, 2026

Number of shareholders of VivoSim Labs, Inc. – NASDAQ:VIVS - TradingView

May 09, 2026

May 08, 2026

Lobbying Update: $10,000 of VIVOSIM LABS INC. lobbying was just disclosed - Quiver Quantitative

May 08, 2026

May 08, 2026

VivoSim Labs, Inc. (VIVS) Eps Diluted (TTM) - Zacks Investment Research

May 08, 2026

May 05, 2026

What VivoSim Labs (VIVS) capital allocation tells us | Q3 2025: Better Than ExpectedGuidance Update - newser.com

May 05, 2026

Apr 28, 2026

VivoSim Platform Predicts Gastrointestinal Toxicity - GlobeNewswire

Apr 28, 2026

Apr 24, 2026

VIVS Price Today: VivoSim Labs, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 23, 2026

VIVS VivoSim Labs notches 32.1 percent Q3 2025 revenue growth, shares edge higher on narrower than expected loss.AI Stock Signals - Newser

Apr 23, 2026

Apr 21, 2026

VivoSim Labs (VIVS) Stock: Is It a Compelling Buy (-4.35%) 2026-04-20Earnings Beat Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 21, 2026

Apr 12, 2026

VIVS Technical Analysis & ETF Price Forecast - Intellectia AI

Apr 12, 2026

Apr 08, 2026

Gap Down: Will VivoSim Labs Inc benefit from AI trendsEarnings Trend Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Apr 08, 2026

Apr 06, 2026

Esousa Group reports 9.9% stake in VivoSim Labs (NASDAQ: VIVS) - Stock Titan

Apr 06, 2026

Apr 05, 2026

VIVS SEC FilingsVivoSim Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 05, 2026

Apr 05, 2026

VivoSim Labs Announces $4 Million Public Offering to Accelerate Adoption of 3D Human Tissue Models for Drug Testing - Minichart

Apr 05, 2026

Apr 03, 2026

VivoSim Labs Prices Best-Efforts Public Offering - TipRanks

Apr 03, 2026

Apr 03, 2026

VivoSim Labs Raises ~$2.5M in Initial Tranche; Signs Purchase and Placement Agreements - TradingView

Apr 03, 2026

Apr 03, 2026

VivoSim Labs (Nasdaq: VIVS) raises $3M in first tranche of $4M deal - Stock Titan

Apr 03, 2026

Apr 02, 2026

VivoSim Labs (NASDAQ: VIVS) registers 3.51M shares with detachable warrants - Stock Titan

Apr 02, 2026

Apr 02, 2026

VIVS Stock Analysis: VivoSim Labs Inc gains 13.68 percent to 1.62 amid bullish momentum - Newser

Apr 02, 2026

Apr 02, 2026

VivoSim Announces Pricing of up to a $4 Million Public Offering - Sahm

Apr 02, 2026

Apr 01, 2026

VivoSim Labs prices $4 million public offering at $1.14/share By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

VivoSim Labs prices $4M public offering at $1.14 per share - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

VivoSim Labs, Inc. (VIVS) stock price, news, quote and history - au.finance.yahoo.com

Apr 01, 2026

Apr 01, 2026

[EFFECT] VivoSim Labs, INC. SEC Filing - Stock Titan

Apr 01, 2026

Mar 31, 2026

VivoSim Labs (NASDAQ: VIVS) outlines $4M two-tranche stock and warrant financing - Stock Titan

Mar 31, 2026

Mar 30, 2026

Aug Breakouts: Is VivoSim Labs Inc benefiting from innovation trendsWeekly Gains Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn

Mar 30, 2026